Cargando…
Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia
Treatments for negative symptoms and cognitive dysfunction in schizophrenia remain issues that psychiatrists around the world are trying to solve. Their mechanisms may be associated with N-methyl-D-aspartate receptors (NMDARs). The NMDAR hypofunction hypothesis for schizophrenia was brought to the f...
Autores principales: | Wu, Qiongqiong, Huang, Jing, Wu, Renrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072017/ https://www.ncbi.nlm.nih.gov/pubmed/33912003 http://dx.doi.org/10.3389/fnins.2021.641047 |
Ejemplares similares
-
NMDAR Hypofunction Animal Models of Schizophrenia
por: Lee, Gloria, et al.
Publicado: (2019) -
Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone
por: Delgado-Sallent, Cristina, et al.
Publicado: (2023) -
Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia
por: Kehrer, Colin, et al.
Publicado: (2008) -
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
por: Snyder, Melissa A., et al.
Publicado: (2013) -
Subunit-specific NMDAR antagonism dissociates schizophrenia subtype-relevant oscillopathies associated with frontal hypofunction and hippocampal hyperfunction
por: Pittman-Polletta, Benjamin, et al.
Publicado: (2018)